表紙:世界のアレルギー診断市場
市場調査レポート
商品コード
897357

世界のアレルギー診断市場

Allergy Diagnostics

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 638 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.87円
世界のアレルギー診断市場
出版日: 2022年03月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 638 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のアレルギー診断市場は、複利成長率10.1%で成長し、32億米ドル成長すると予測されています。アッセイキットの成長率は10.9%となっています。

当レポートでは、世界のアレルギー診断市場について調査し、市場の概要とセグメント別動向、地域別動向、および主要企業のプロファイルについてまとめています。

第1章 イントロダクション、調査方法、調査範囲

第2章 エグゼクティブサマリー

  • 市場概要
    • アレルギー;序論
    • アレルギーの症状と原因
    • 成長動向
    • 世界の罹患率
    • 世界のアレルギー市場動向
    • アッセイキットが市場を独占
    • 米国が市場を独占するも中国が最速で成長
    • 地域別市場
    • 体外診断検査需要の高まり
    • セグメント別市場収益
    • 地域別市場収益
    • 競合環境
  • 主要参入企業
  • 市場動向と促進因子
    • 効果的なアレルギー診断製品の開発
    • 世界の年間医療費
    • 一人当たりの医療費
    • 体外分子診断
    • マクロアレイ診断
    • アルコールと薬物乱用の増加がアレルギー検査需要を拡大
    • 症例増加が最新のアレルギー診断ソリューション開発を促進
    • IgE抗体検査
    • マイクロチップのアレルギー診断試薬 他
  • 世界市場見通し
  • 市場分析
    • 米国
    • カナダ
    • 日本
    • 中国
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東
    • アフリカ

第4章 競合

目次
Product Code: MCP10238

What`s New for 2022?

» Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

» Online interactive peer-to-peer collaborative bespoke updates

» Access to our digital archives and MarketGlass Research Platform

» Complimentary updates for one year

Global Allergy Diagnostics Market to Reach US$5.7 Billion by the Year 2026

Allergy represents a medical condition characterized by exaggerated or abnormal response of the immune system to harmless substances or allergens, causing signs like skin irritation, itchiness, swelling, red eyes, hay-fever, anaphylaxis or asthma attack. There are different types of allergies, including skin and dust allergy, drug allergy, food allergy, and insect stings allergy. There are different types of blood and skin tests that help healthcare providers in detecting an allergy. The diagnosis defines the nature of allergic condition along with the treatment course. The global allergy diagnostics market, after decelerating for a while owing to the Covid-19 effect, is back up and growing, led by increasing cases of allergy resulting from exposure to pollution, and increased consumption of processed food as well as dairy and confectionary products. The growing prevalence of allergy and associated health implications warrants a pressing need for effective diagnosis and treatment. The rapidly increasing incidence of allergy coupled with changing dietary habits is playing a pivotal role in bolstering the allergy diagnostics market. The market growth is also augmented by increasing level of environmental pollution and the resulting increase in the number of individuals suffering from allergic conditions. Changing lifestyles and dietary patterns coupled with rapid urbanization and increasing level of outdoor and indoor pollution are likely to increase the incidence of allergic conditions. The market growth is estimated to be also propelled by strong demand for in-vitro diagnostic blood tests.

Amid the COVID-19 crisis, the global market for Allergy Diagnostics estimated at US$3.8 Billion in the year 2022, is projected to reach a revised size of US$5.7 Billion by 2026, growing at a CAGR of 9.3% over the analysis period. Assay Kits, one of the segments analyzed in the report, is projected to grow at a 10% CAGR to reach US$3.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 9.2% CAGR for the next 7-year period. This segment currently accounts for a 28.2% share of the global Allergy Diagnostics market. Assay kits are anticipated to witness high demand fueled by key factors such as rising preference for assay kits by medical practitioners in allergy testing, high prevalence of allergic diseases, and increasing test volumes. The high product availability and need for repeat purchase in allergy testing is also expected to drive high consumption of assay kits in the coming years. Despite the high cost of instruments, the segment is forecast to hold a significant share due to the long lifespan of instruments and limited need for frequent installations. The procurement of used instruments by smaller healthcare organizations also expands market share for instruments.

The U.S. Market is Estimated at $1.3 Billion in 2022, While China is Forecast to Reach $622.5 Million by 2026

The Allergy Diagnostics market in the U.S. is estimated at US$1.3 Billion in the year 2022. The country currently accounts for a 34.21% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$622.5 Million in the year 2026 trailing a CAGR of 13.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.1% and 8.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.8% CAGR while Rest of European market (as defined in the study) will reach US$189.6 Million by the end of the analysis period. Although developed regions constitute major revenue contributors, developing regions have emerged as hot spots for future growth of allergy diagnostics market. Factors such as increasing public and private sector investments in healthcare domain, rising incidence of allergies, and improvement in healthcare access and rising awareness levels, are favoring market growth in the developing regions.

Services Segment to Reach $1.1 Billion by 2026

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 7.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$544.4 Million will reach a projected size of US$872.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$124.1 Million by the year 2026, while Latin America will expand at a 9.6% CAGR through the analysis period.

Select Competitors (Total 100 Featured) -

  • Alk-Abello A/S
  • Allergy Therapeutics PLC
  • ALPCO
  • Angsana Molecular & Diagnostics Laboratory Pte. Ltd.
  • Astra Biotech GmbH
  • biomerieux SA
  • Demeditec Diagnostics GmbH
  • EUROIMMUN Medizinische Labordiagnostika AG
  • GA Generic Assays GmbH
  • INDOOR Biotechnologies, Inc.
  • Lincoln Diagnostics, Inc.
  • Omega Diagnostics Group Plc
  • R-Biopharm Ag
  • Roxall Medizin GmbH
  • Siemens Healthineers
  • Stallergenes Greer
  • Tecan Trading AG
  • Theradiag
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Allergens: A Prelude
    • Key Allergy Stats
    • Allergy: Symptoms and Causes
    • Allergic Diagnostics: An Introduction
    • Food Allergen Testing
    • Impact of Covid-19 and a Looming Global Recession
    • The Never-Ending "Race" Between the Virus & Vaccines Continues. Amidst this Chaotic Battle, Where is the World Economy Heading Now & Beyond?
    • Omicron Variant Brings Back Memories & Fears of the Worst Part of the 2020 Pandemic
    • EXHIBIT 1: Time is of Essence! What We Know So Far - "Vaccine Efficiency against New Strains"
    • With New Strains Emerging at an Alarming Rate, Focus Shifts to Booster Doses & Vaccine Tweaking. But How Practical Is It to Implement Them?
    • EXHIBIT 2: With Vaccinated Population Showing Signs of Declining Clinical Protection, Booster Doses Are Emerging Into a Necessity to Restore Vaccine Effectiveness: Number of Booster Doses Administered Per 100 People by Country as of December 2021
    • With IMF Making an Upward Revision of Global GDP for 2022, Companies Are Bullish About a Continuing Economic Comeback despite a Prolonging Pandemic
    • EXHIBIT 3: A Strong Yet Uncertain Recovery Shaped by New Variants Comes Into Play: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • Allergy Diagnostics Market Under the Covid Lens
    • Telemedicine Gains Prominence amid the Pandemic
    • Global Allergy Diagnostics Market Set to Witness Rapid Growth
    • With Allergies on the Rise for Whatever Reason Be It Our Neanderthal Genes or Hygiene Hypothesis or Vitamin D Hypothesis, the Need for Effective Diagnostics Has Never Been Greater
    • EXHIBIT 4: Global Prevalence of Allergies (In Million)
    • Assay Kits Dominate the Allergy Diagnostics Market
    • Inhaled Allergens Segment to Witness Fastest Growth
    • US Dominates the Allergy Diagnostics Market, While China to Witness the Fastest Growth
    • Rising Demand for In-Vitro Diagnostic Tests for Allergy Diagnosis
    • EXHIBIT 5: Global In-Vitro Diagnostics (IVD) Market Revenues (in %) by Segment for the Year 2021
    • EXHIBIT 6: Global In-Vitro Diagnostics (IVD) Market Revenues (in %) by Geographic Region for the Year 2021
    • Allergy Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
    • EXHIBIT 7: Allergy Diagnostics Competitor Market Share Scenario Worldwide (in %): 2021
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 67 Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Development of Effective Allergy Diagnostic Products Cuts Down on Healthcare Spending
    • EXHIBIT 8: World Healthcare Expenditure (In US$ Trillion) for the Years 2017, 2019, 2021 & 2023
    • EXHIBIT 9: Per Capita Healthcare Expenditure (in $) by Select Countries for 2018
    • Labs Embrace Automation and Advanced Allergy Tests for Fast Turnaround Times
    • Food Allergies - A Major and Growing Concern
    • Select Digital Technologies to Provide Help in Managing Food Allergy
    • Food Allergies Create Opportunities for Food Allergy Testing
    • ELISA Gains Lead as Preferred Food Testing Method
    • Need to Offer Quality Services at Affordable Costs Prompts Labs to Consider Reagent Rental Agreements
    • In-Vitro IgE Molecular Diagnostics to Transform Allergy Testing Market
    • Macro Array Diagnostics Unveils Allergy Explorer for Allergy Diagnostics
    • Rising Alcohol and Drug Abuse Increases Demand for Allergy Diagnostics
    • Increasing Cases of Allergies Drive Development of Advanced Allergy Diagnostics Solutions
    • Focus on Single and Protein Allergens
    • IgE Antibody Tests
    • Allergy Diagnostic Reagents on Microchip
    • Allergy Diagnosis Moves from Lab-based to Decentralized POC Tests
    • Patch Test to Experience Healthy Growth
    • SmartPractice Secures FDA Approval for T.R.U.E. Test(R) Patch Test for Pediatric Use
    • Providers of Allergy Diagnostic Services Focus on Vertical Integration
    • Allergic Diagnostic Challenges in Patients
    • Enhanced Access to Allergy Diagnosis Medical Insurance & Instrument Allowances in the US Widen Market Prospects
    • EXHIBIT 10: Typical Cost Structure for Allergy Testing
    • Technological Advancements - Mobile Health Tools for Allergy Patients
    • Technological Advancements - Nanotechnology for Allergy Diagnostics
    • Application of Nanostructures for In-Vitro Diagnosis of Allergy
    • Application of Nanostructures in Drug-sIgE Detection
    • Application of Nanostructures for Detection of Allergen-sIgE
    • Select Recent Launches in the Allergy Diagnostics Market to Bolster Market Expansion
    • EUROIMMUM Develops EUROLINE DPA-Dx Pollen Southern Europe 1 Test for Pollen Allergies
    • Hycor Biomedical Secures FDA Clearance for NOVEOS Allergy Testing System
    • ASI Introduces IVT Allergy(R) 3 Screen Panel for Allergy Skin Testing
    • CLA-1(TM) Luminometer In-Vitro Allergy Testing Platform for Accurate, Reliable Results
    • Growth Drivers
    • Increasing Prevalence and Incidence of Allergic Disorders to Drive the Demand for Allergy Diagnostics
    • EXHIBIT 11: Atopic Dermatitis (Eczema) Prevalence Rates among Global Adult Population
    • Environmental Changes and Pollution Aggravate Incidence of Allergic Reactions, Resulting in Increased Need for Allergy Diagnostics
    • Major Environmental Factors with Link to Allergic Diseases
    • Growing Number of Food Allergy Cases Fuels Demand for Allergy Testing Kits
    • EXHIBIT 12: Prevalence Rate of Five Common Food Allergies among US Adults
    • Factors Responsible for Rising Prevalence of Food Allergy
    • Burgeoning Aging Population and Longer Life Expectancy to Drive Allergy Diagnostics Market
    • EXHIBIT 13: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Market Restraints
    • Inadequate Knowledge about Food Allergy Inhibits Growth of Allergy Diagnostic Market
    • Expensive Nature of Allergy Diagnostics Approaches Limits Market Growth
    • New Regulations and Statutory Provisions to Affect Diagnostic Allergen Extracts
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Allergy Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Allergy Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Allergy Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
    • TABLE 4: World Recent Past, Current & Future Analysis for Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Assay Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 10: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 13: World Recent Past, Current & Future Analysis for Inhaled Allergens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Inhaled Allergens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Inhaled Allergens by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 16: World Recent Past, Current & Future Analysis for Food Allergens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Food Allergens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Food Allergens by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 19: World Recent Past, Current & Future Analysis for Drug Allergens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Drug Allergens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Drug Allergens by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Allergens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Other Allergens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other Allergens by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 28: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 31: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 32: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • Allergy Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
    • Allergy Prevalence Statistics
    • Incidences of Food Allergy and Intolerance on the Rise among Americans
    • Pain Killer Abuse Leads to High Incidence of Drug Allergy Reactions
    • US Witnesses Increasing Popularity of At-Home Allergy Diagnostic Kits
    • US Offers Favorable Reimbursements for Allergy Testing
    • Market Analytics
    • TABLE 34: USA Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 37: USA Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: USA Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: USA 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 40: USA Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: USA Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: USA 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • CANADA
    • TABLE 43: Canada Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Canada 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Canada Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Canada 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 49: Canada Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Canada Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Canada 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • JAPAN
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Japan Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Japan 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 55: Japan Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Japan Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Japan 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Japan Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Japan 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • CHINA
    • TABLE 61: China Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: China 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 64: China Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: China Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: China 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 67: China Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: China Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: China 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • EUROPE
    • Allergy Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
    • Food Allergy: Regulatory Overview
    • EU FIC Regulation
    • Soy Allergy Regulations
    • Egg Allergy Regulations
    • Market Analytics
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Allergy Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Allergy Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for Allergy Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
    • TABLE 73: Europe Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Europe 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Europe Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Europe 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 79: Europe Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Europe Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Europe 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • FRANCE
    • TABLE 82: France Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: France Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: France 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 85: France Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: France Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: France 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 88: France Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: France Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: France 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • GERMANY
    • TABLE 91: Germany Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Germany 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Germany Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Germany 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 97: Germany Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Germany Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Germany 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • ITALY
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Italy Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Italy 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 103: Italy Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Italy Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Italy 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Italy Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Italy 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • UNITED KINGDOM
    • TABLE 109: UK Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UK Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: UK 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 112: UK Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: UK Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: UK 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 115: UK Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: UK Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: UK 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • SPAIN
    • TABLE 118: Spain Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Spain Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Spain 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 121: Spain Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Spain Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Spain 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 124: Spain Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Spain Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Spain 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • RUSSIA
    • TABLE 127: Russia Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Russia Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Russia 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 130: Russia Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Russia Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Russia 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 133: Russia Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Russia Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Russia 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF EUROPE
    • TABLE 136: Rest of Europe Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Europe Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of Europe 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 139: Rest of Europe Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Rest of Europe Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Rest of Europe 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 142: Rest of Europe Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Rest of Europe Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Rest of Europe 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • ASIA-PACIFIC
    • Allergy: An Overview
    • Market Analytics
    • TABLE 145: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for Allergy Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 15-Year Perspective for Allergy Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
    • TABLE 148: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Asia-Pacific Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Asia-Pacific 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 151: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Asia-Pacific Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Asia-Pacific 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 154: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Asia-Pacific Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Asia-Pacific 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • AUSTRALIA
    • TABLE 157: Australia Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Australia Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Australia 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 160: Australia Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Australia Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: Australia 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 163: Australia Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Australia Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: Australia 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • INDIA
    • Food Allergies and Intolerances on the Rise among Indians
    • Market Analytics
    • TABLE 166: India Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: India Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: India 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 169: India Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: India Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: India 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 172: India Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: India Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: India 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • SOUTH KOREA
    • TABLE 175: South Korea Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: South Korea Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: South Korea 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 178: South Korea Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: South Korea Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: South Korea 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 181: South Korea Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: South Korea Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: South Korea 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 184: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of Asia-Pacific Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Rest of Asia-Pacific 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 187: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Rest of Asia-Pacific Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Rest of Asia-Pacific 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 190: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Rest of Asia-Pacific Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Rest of Asia-Pacific 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • LATIN AMERICA
    • TABLE 193: Latin America Recent Past, Current & Future Analysis for Allergy Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 194: Latin America Historic Review for Allergy Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Latin America 15-Year Perspective for Allergy Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
    • TABLE 196: Latin America Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Latin America Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Latin America 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 199: Latin America Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Latin America Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Latin America 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 202: Latin America Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Latin America Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Latin America 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • ARGENTINA
    • TABLE 205: Argentina Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Argentina Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Argentina 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 208: Argentina Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Argentina Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Argentina 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 211: Argentina Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Argentina Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Argentina 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • BRAZIL
    • TABLE 214: Brazil Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Brazil Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Brazil 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 217: Brazil Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Brazil Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 219: Brazil 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 220: Brazil Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 221: Brazil Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 222: Brazil 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • MEXICO
    • TABLE 223: Mexico Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 224: Mexico Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 225: Mexico 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 226: Mexico Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 227: Mexico Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 228: Mexico 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 229: Mexico Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Mexico Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 231: Mexico 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF LATIN AMERICA
    • TABLE 232: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 233: Rest of Latin America Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 234: Rest of Latin America 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 235: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 236: Rest of Latin America Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 237: Rest of Latin America 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 238: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 239: Rest of Latin America Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 240: Rest of Latin America 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • MIDDLE EAST
    • TABLE 241: Middle East Recent Past, Current & Future Analysis for Allergy Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 242: Middle East Historic Review for Allergy Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 243: Middle East 15-Year Perspective for Allergy Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
    • TABLE 244: Middle East Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 245: Middle East Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 246: Middle East 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 247: Middle East Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 248: Middle East Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 249: Middle East 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 250: Middle East Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 251: Middle East Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 252: Middle East 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • IRAN
    • TABLE 253: Iran Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 254: Iran Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 255: Iran 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 256: Iran Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 257: Iran Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 258: Iran 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 259: Iran Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 260: Iran Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 261: Iran 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • ISRAEL
    • TABLE 262: Israel Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 263: Israel Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 264: Israel 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 265: Israel Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 266: Israel Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 267: Israel 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 268: Israel Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 269: Israel Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 270: Israel 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • SAUDI ARABIA
    • TABLE 271: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 272: Saudi Arabia Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 273: Saudi Arabia 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 274: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 275: Saudi Arabia Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 276: Saudi Arabia 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 277: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 278: Saudi Arabia Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 279: Saudi Arabia 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 280: UAE Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 281: UAE Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 282: UAE 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 283: UAE Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 284: UAE Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 285: UAE 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 286: UAE Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 287: UAE Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 288: UAE 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF MIDDLE EAST
    • TABLE 289: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 290: Rest of Middle East Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 291: Rest of Middle East 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 292: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 293: Rest of Middle East Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 294: Rest of Middle East 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 295: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 296: Rest of Middle East Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 297: Rest of Middle East 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027
  • AFRICA
    • TABLE 298: Africa Recent Past, Current & Future Analysis for Allergy Diagnostics by Product - Assay Kits, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 299: Africa Historic Review for Allergy Diagnostics by Product - Assay Kits, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 300: Africa 15-Year Perspective for Allergy Diagnostics by Product - Percentage Breakdown of Value Revenues for Assay Kits, Instruments and Services for the Years 2012, 2021 & 2027
    • TABLE 301: Africa Recent Past, Current & Future Analysis for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 302: Africa Historic Review for Allergy Diagnostics by Allergens - Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 303: Africa 15-Year Perspective for Allergy Diagnostics by Allergens - Percentage Breakdown of Value Revenues for Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens for the Years 2012, 2021 & 2027
    • TABLE 304: Africa Recent Past, Current & Future Analysis for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 305: Africa Historic Review for Allergy Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 306: Africa 15-Year Perspective for Allergy Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2012, 2021 & 2027

IV. COMPETITION

  • Total Companies Profiled: 100